Medicines Evaluation Unit

The Medicines Evaluation Unit (MEU) was established and founded in 1994 by the late Dr Steve Langley, and is a joint venture with UHSM.

We are a leading specialist clinical research facility working with the pharmaceutical industry to identify potential new treatments for conditions such as Asthma, Bronchitis and Emphysema.

We specialise in performing clinical trials (from Phase I through to IV) in respiratory and inflammatory medicine and their related areas. Based within the hospital premises, the MEU has the advantages of specialist equipment and ITU availability – making it ideally suited to perform early phase exploratory studies.

The wellbeing of our volunteers is always our first priority and we have an outstanding reputation within the industry for performing high quality clinical research complying with strict clinical trial legislation. We have successfully conducted over 200 clinical trials and this number continues to grow.

We are wholly owned by the North West Lung Centre Charity and due to the unique way that we operate, all profits generated by us are then reinvested into the research of future treatments for respiratory diseases.

We are located in our own purpose built state of the art facility on the grounds of Wythenshawe Hospital and employ a team of dedicated medical professionals who are committed to excellence.

If you are interested in volunteering for clinical trials visit the volunteer website: www.rewardingresearch.co.uk

Location

The MEU is located in the Langley Building, in between the Nightingale Centre and the Clinical Sciences Building, on Southmoor Road (on the opposite side from the main UHSM buildings).

Contact

Reception: 0161 946 4050
Fax: 0161 946 1685